King’s College London researchers discovered that parts of our DNA once thought to be “junk” can actually help destroy cancer ...

A new preliminary study published in Nature suggests that COVID-19 vaccines might actually boost the immune system to make ...

Syndax received expanded FDA approval for Revuforj, tripling its addressable AML patient population despite a boxed safety ...

Scientists have discovered how leukemia cells outsmart a leading treatment and may have found a way to stop them. Scientists ...

The drug, which is an NLRP3 inhibitor, also reduced other key cardiovascular risk biomarkers. Ventyx Biosciences plans to ...

A collaborative research group has developed a novel therapeutic candidate that may improve the prognosis of severe cutaneous ...

Early CRP levels may predict progression-free and overall survival among patients with stage IV MM undergoing first-line ICI therapy.

Getting a COVID shot might do more than protect against the virus – it could also help cancer patients live longer. A new ...

Background Lupus nephritis (LN) is the most serious complication of SLE. Interstitial fibrosis is the dominant pathological ...

Hefei Institutes of Physical Sciences has synthesized new pyrazoleamide compounds acting as receptor-interacting serine/threonine-protein kinase 1 (RIPK1; RIP-1) inhibitors reported to be useful for ...

Combining proteasome inhibitors with autophagy inhibitors disrupts acute myeloid leukemia (AML) cells' proteostasis, ...

Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced updated clinical data for ...